Zhejiang Dayang Biology Technology Co.,Ltd. (003017.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 2.03B |
| Enterprise Value | 1.95B |
| P/E Ratio | 17.38 |
| PEG Ratio | 0.73 |
| Price/Sales Ratio | 1.91 |
| Price/Book Ratio | 1.86 |
| Enterprise/Revenue | 1.96 |
| Enterprise/EBITDA | 9.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.11 |
| Return On Assets | 0.05 |
| Return On Equity | 0.09 |
| Revenue | 1.05B |
| Revenue/Share | 11.01 |
| Gross Profit | 239.39M |
| EBITDA | 183.69M |
| Net Income | 99.85M |
| Diluted EPS | 1.21 |
| Total Cash | 397.61M |
| Total Cash/Share | 3.96 |
| Total Debt | 452.34M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1 |
| Book Value Per Share | 11.72 |
| 52-Week Change | -26 |
| 52-Week High | 30.83 |
| 52-Week Low | 18.82 |
| Moving Average 50 Days | 21.99 |
| Moving Average 200 Days | 24.68 |
| Average Volume | 2.21M |
| Shares Outstanding | 97M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.55 |
| Trailing Annual Dividend Yield | 2.53 |
| Payout Ratio | 0.49 |
| Last Split Factor | 6:5 |
| Last Split Date | June 26, 2026 |